Shanghai Pharmaceuticals Holding Co.,Ltd.



Quote for Shanghai Pharmaceuticals Holding Co.,Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
601607
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8601607 quote

Summary for Shanghai Pharmaceuticals Holding Co.,Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd is principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its businesses primarily through the research, development and manufacture of pharmaceuticals, which offers Chinese medicines, chemical drugs, biological products, biochemical drugs and other healthcare products; pharmaceuticals distribution and supply chain solutions, which provides distribution, logistics, warehousing and other pharmaceutical supply chain value-added solutions and related services, as well as pharmaceutical retailing business, which involves in operation and management of regular chain drugstores. The Company provides ulinastatin, ceftriaxone sodium and hydroxychloroquine, among others. The Company distributes its products in domestic and overseas markets.

Profile for Shanghai Pharmaceuticals Holding Co.,Ltd.

Full Name:Shanghai Pharmaceuticals Holding Co.,Ltd.
Full Name in Chinese:上海医药集团股份有限公司 Short Name in Chinese:上海医药
Symbol/Stock Code:
601607
Listed in:
Shanghai Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Lv Mingfang
Secretary of the Board:
Han Min
Phone:
+86-21-63730908
Fax:
+86-21-63289333
Official Website:www.pharm-sh.com.cn
E-mail:pharm@pharm-sh.com.cn
Address:Shanghai Pharmaceutical Mansion,No.200 Taicang Road,SHANGHAI SHA 200020
IPO Subscription Date:
1993-10-08
Listing Date:
1994-03-24
IPO Issued Capital:
15000000
IPO Price:
4.5 CNY
IPO fees:
1352300 CNY
Money Raised by IPO:
67500000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
66147700 CNY
Open(Listing day):
22.98 CNY
Close(Listing day):
18.49 CNY
Diluted P/E ratio after IPO:
13.1400
Turnover rate(listing day):
-%

Financials for Shanghai Pharmaceuticals Holding Co.,Ltd.

UPDATE:2012-11-02 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
1546.8365
2042.2385
1456.1948
1296.7895
Net Profit Growth(%)
-9.70
40.24
12.29
1481.78
Return On Equity(ROE)(%)
6.43
8.85
14.55
15.66
Debt ratio(%)
46.50
45.49
57.47
52.29
Net Operating Cash Flow/Net Profit(%)
45.72
86.79
151.82
147.35

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.5753
0.8437
0.7308
0.6508
Diluted Earnings Per Share
0.5340
0.5883
0.6068
0.3893
Net Asset Value Per Share (NAVPS)
8.9500
8.5800
5.0200
4.1600
Additional Paid-In Capital Per Share
5.3737
5.3888
1.9303
2.4861
Retained Earnings Per Share
2.3243
1.9325
1.7632
1.0966
Net Cash Flow From Operatings Activities Per Share
0.2630
0.6600
1.1100
0.9600
Net Cash Flow Per Share
-0.6015
3.1032
0.6556
0.7985

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
51129.6674
47667.8229
28169.0202
8656.9742
Total Liabilities(Million)
23776.2295
21686.3572
16284.7567
6334.5558
Current Liabilities(Million)
22618.3184
20855.9102
15917.546
6258.1222
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
13208.934
14850.0537
6338.3372
1221.9512
Accounts Receivables(Million)
14824.8367
10606.3646
6794.3544
3027.5898
Deposit Received(Million)
338.3479
371.2599
309.4709
102.8036
Other Receivables(Million)
512.5249
595.158
513.2367
121.3657
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
24066.0674
23078.4722
10009.7188
8282.0066
Debt ratio(%)
46.50
45.49
57.47
52.29
Equity Ratio(%)
47.0600
48.4100
33.1800
37.8600
Current Ratio
1.7225
1.7259
1.2989
1.3253
Quick Ratio
1.3341
1.3280
0.9905
0.9902

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
53999.7308
60972.5015
42716.427
35740.2453
Net Cash Flow From Operatings Activities(Million)
707.2112
1772.438
2210.7904
1910.7928
Net Cash Flow From Operatings Activities Change(%)
56.00
-19.83
15.70
568.86
Net Cash Flow(Million)
-1617.4397
8344.2593
1306.3158
1591.1328
Cash From Selling Commodities/Prime Revenue(%)
105.58
111.06
110.32
114.33
Net Cash Flow/Net Profit(%)
-104.56
408.58
89.71
122.70
Cash Flow From Investing Activities(Million)
-656.5915
-3790.4235
-2988.2998
287.0306
Cash Flow From Financing Activities(Million)
-1719.7652
10643.0569
2089.3366
-607.1012

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
51147.3033
54899.8725
38721.6552
31260.8807
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
2905.1668
3288.6869
3071.5213
2625.3737
Administrative Costs(Million)
1765.0779
2134.3865
1914.9923
1650.0953
Financing Costs(Million)
154.8061
472.9275
237.2009
198.287
Above Three Costs Change(%)
13.12
12.87
16.76
262.96
Operating Profit(Million)
2204.2848
2873.7284
2181.6792
2072.0833
Income From Investment(Million)
298.0465
933.9146
430.7533
961.0145
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
102.9411
161.3737
101.573
57.9614
Total Profit(Million)
2307.2259
3035.1021
2283.2522
2130.0447
Corporate Income Tax(Million)
464.6528
589.0724
415.887
464.8546
Net Profit(Million)
1546.8365
2042.2385
1456.1948
1296.7895
Gross Profit Ratio(%)
13.45
14.60
18.39
18.96
Operating Margin(%)
4.30
5.23
5.63
6.62
Return On Equity(ROE)(%)
6.43
8.85
14.55
15.66